Fullhope Biomedical Co.,Ltd
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 2012-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.fhb.com.tw
Dendritic Killer Cell-based Immunotherapy for Solid Tumors
Phase 1
- Conditions
- Hepatocellular CarcinomaNeoplasm MetastasisColorectal Neoplasms
- Interventions
- Biological: Dendritic Killer Cell (DKC)
- First Posted Date
- 2016-08-30
- Last Posted Date
- 2016-08-30
- Lead Sponsor
- FullHope Biomedical Co., Ltd.
- Target Recruit Count
- 18
- Registration Number
- NCT02882659
© Copyright 2025. All Rights Reserved by MedPath